Hematopoietic repopulating ability of CD34⁺ progenitor cells ex vivo expanded with different cytokine combinations

References

• Broxmeyer HE, Gluckman E, Auerbach A, Douglas GW, Friedman H, Cooper S, et al. 1990. Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Cloning. 8:76–91.
   PubMedGoogle Scholar
• Bryder D, Jacobsen SE. 2000. Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro. Blood. 96:1748–1755.
   PubMed Web of Science ®Google Scholar
• Chute JP, Muramoto G, Fung J, Oxford C. 2004. Quantitative analysis demonstrates expansion of SCID-Repopulating cells and increased engraftment capacity in human cord blood following ex vivo culture with human brain endothelial cells. Stem Cells. 22:202–215.
   PubMed Web of Science ®Google Scholar
• Cláudia LS, Pedro ZA, Francisco S, Joaquim MS. 2011. Ex-vivo expansion of hematopoietic stem cells from umbilical cord blood, 1st Portuguese Meeting in Bioengineering (ENBENG).
   Google Scholar
• Danet GH, Lee HW, Luongo JL, Simon MC, Bonnet DA. 2001. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34+ cells after ex vivo expansion. Exp Hematol. 29:1465–1473.
   PubMed Web of Science ®Google Scholar
• Guzman PF, Rodriguez MG, Mayani H. 2002. In vitro proliferation, expansion, and differentiation of a CD34+ cell-enriched hematopoietic cell population from human umbilical cord blood in response to recombinant cytokines. Arch Med Res. 33:107–114.
   PubMed Web of Science ®Google Scholar
• Higuchi A, Yang ST, Li PT, Tamai M, Tagawa Y, Chang Y, et al. 2010. Direct ex vivo expansion of hematopoietic stem cells from umbilical cord blood on membranes. J Membr Sci. 351:104–111.
   Web of Science ®Google Scholar
• Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M. 1987. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci. 84:9035–9039.
   PubMed Web of Science ®Google Scholar
• Jaroscak J, Goltry K, Smith A, Waters-Pick B, Martin PL, Driscoll TA, et al. 2003. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo–expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood. 101:5061–5067.
   PubMed Web of Science ®Google Scholar
• Kishimoto S, Nakamura S, Hattori H, Oonuma F, Kanatani Y, Tanaka Y, et al. 2009. Cytokine-immobilized microparticle-coated plates for culturing hematopoietic progenitor cells. J Control Release. 133:185–190.
   PubMed Web of Science ®Google Scholar
• Kiyoshi A, Takashi Y, Tadayuki S, Hiroko M, Hideyuki M, Masayuki O, et al. 2006. Direct evidence for ex vivo expansion of human hematopoietic stem cells. Blood. 107:3371–3377.
   PubMed Web of Science ®Google Scholar
• Koen VB. 2011. Cord blood transplant: the glass is half full-can we do better?Leuk Lymphoma. 52:554–555.
   PubMed Web of Science ®Google Scholar
• Kusadasi N, van Soest PL, Mayen AE, Koevoet JL, Ploemacher RE. 2000. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood. Leukemia. 14:1944–1953.
   PubMed Web of Science ®Google Scholar
• Li C, Ando K, Kametani Y, Oki M, Hagihara M, Shimamura K, et al. 2002. Reconstitution of functional human B lymphocytes in NOD/SCID mice engrafted with ex vivo expanded CD34+ cord blood cells. Exp Hematol. 30:1036–1043.
   PubMed Web of Science ®Google Scholar
• Li QL, Cai HB, Liu QW, Tan WS. 2006. Differential gene expression of human CD34+ hematopoietic stem and progenitor cells before and after culture. Biotechnol Lett. 28:389–394.
   PubMed Web of Science ®Google Scholar
• Loretta G, Stefania B, Fiorella S, Monica G, Orit K, Giuliana C, et al. 2003. Ex vivo expansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution. Exp Hematol. 31:261–270.
   PubMed Web of Science ®Google Scholar
• Luens KM, Travis MA, Chen BP, Hill BL, Scollay R, Murray LJ. 1998. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin− cells with preserved ability to engraft SCID-hu bone. Blood. 91:1206–1215.
   PubMed Web of Science ®Google Scholar
• McNiece IK, Almeida-Porada G, Shpall EJ, Zanjani E. 2002. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol. 30: 612–616.
   PubMed Web of Science ®Google Scholar
• Noort WA, Wilpshaar J, Hertogh CD, Rad M, Lurvink EG, van Luxemburg-Heijs SA, et al. 2001. Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34+ cells from umbilical cord blood as compared to adult sources. Bone Marrow Transplant. 28:163–171.
   PubMed Web of Science ®Google Scholar
• Olga T, Barclay GT, Huw R, John D, Marc LT. 2007. Optimal ex vivo expansion of neutrophils from PBSC CD34+ cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO. J Transl Med. 5:53.
   PubMed Web of Science ®Google Scholar
• Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ. 1996. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL- 6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood. 87:30–37.
   PubMed Web of Science ®Google Scholar
• Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, et al. 2001. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood. 97:2962–2971.
   PubMed Web of Science ®Google Scholar
• Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E. 2000. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med. 342:1846–1854.
   PubMed Web of Science ®Google Scholar
• Ueda T, Tsuji K, Yoshino H, Ebihara Y, Yagasaski H, Hisakawa H, et al. 2000. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest. 105:1013–1021.
   PubMed Web of Science ®Google Scholar
• Wilpshaar J, Noort WA, Kanhai HH, Willemze R, Falkenburg JH. 2001. Engraftment potential into NOD/SCID mice of CD34+ cells derived from human fetal liver as compared to fetal bone marrow. Haematologica. 86:1021–1028.
   PubMed Web of Science ®Google Scholar
• Xu MJ, Tsuji K, Ueda T, Mukouyama YS, Hara T, Yang FC, et al. 1998. Stimulation of mouse and human primitive hematopoiesis by murine embryonic Aorta-Gonad-Mesonephros–derived stromal cell lines. Blood. 92:2032–2040.
   PubMed Web of Science ®Google Scholar
• Yang S, Cai HB, Jin HL, Tan WS. 2008. Hematopoietic reconstitution of CD34+ cells grown in static and stirred culture systems in NOD/SCID mice. Biotechnol Lett. 30:61–65.
   PubMed Web of Science ®Google Scholar
• Yang S, Cai HB, Jin HL, Tan WS. 2009. Hematopoietic reconstitution of CD34+ cells derived from short-term cultured cord blood mononuclear cells. Biotechnol Bioprocess Eng. 14:429–435.
   Web of Science ®Google Scholar
• Yao CL, Chu IM, Hsieh TB, Hwang SM. 2004. A systematic strategy to optimize ex vivo expansion medium for human hematopoietic stem cells derived from umbilical cord blood mononuclear cells. Exp Hematol. 32:720–727.
   PubMed Web of Science ®Google Scholar